Financials • Accident &Health Insurance
$91.59 ▲ +1.34
(+1.49%)
MKT CAP: $14.50B • VOL: 1.00M
52W L $69 52W H $97
UNM // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $13.08B | $12.89B | $12.39B |
| YoY Revenue Growth % | +1.5% | +4.0% | — |
| Gross Profit | $5.75B | $5.67B | $5.45B |
| Gross Margin % | 44.0% | 44.0% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $871.4M | $2.10B | $1.51B |
| Operating Margin % | 6.7% | 16.3% | 12.2% |
| Net Income (GAAP) | $738.5M | $1.78B | $1.28B |
| EBITDA (Normalized) | $977.3M | $2.20B | $1.96B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $687.7M | $1.51B | $1.20B |
| Capital Expenditures (CapEx) | $132.3M | $125.7M | $557.4M |
| Free Cash Flow (FCF) | $555.4M | $1.39B | $645.4M |
| FCF Margin % | 4.2% | 10.8% | 5.2% |
| Return on Invested Capital (ROIC %) | 8.7% | 21.8% | 13.3% |
| Cash & Short-Term Equivalents | $6.99B | $6.82B | $1.63B |
| Total Debt (Short + Long Term) | $3.77B | $3.47B | $3.48B |
| Total Stockholders' Equity | $11.12B | $10.96B | $7.13B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR UNM.